Walter Fiedler

Prof. Dr. Walter Fiedler is affiliated with the University Medical Center Hamburg-Eppendorf as a faculty member in the II. Medical Clinic and Polyclinic. His research focuses on acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and molecular mechanisms of gene mutations in hematologic malignancies.

• Key Research Areas: Hematology, Molecular Oncology, Leukemia Signal Transduction, Immune Checkpoint Modulation, and Prognostic Risk Modeling.

Recent publications highlight therapeutic strategies for FLT3-ITD AML (e.g., fatty acid synthase inhibition, midostaurin), CD39/CD73 pathway in immune exhaustion, and venetoclax combinations for high-risk leukemia. He collaborates on phase 1b/2a trials for targeted therapies and contributes to bone metastasis immunology and TIGIT axis research.

• Scientific Collaborations: German-Austrian AML Study Group, University Cancer Center Hamburg (UCCH), and international clinical trial networks.

His work bridges translational research and clinical practice, emphasizing personalized treatment approaches for leukemia patients.